However, some of our research results contrasted with the findings reported in another study by Camblor et al., which found that certain variants in the NF‐κB genes (NFKB1, NFKBIA, and NFKBIZ) may increase the risk of developing severe COVID‐19. This evidence concerns the gene NFKB1 and COVID-19.